GemVax&KAEL Co.Ltd (082270) — Capital Reinvestment Ratio

Latest as of December 2025: 0.14x

GemVax&KAEL Co.Ltd (082270) has a Capital Reinvestment Ratio of 0.14x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩10.34 Billion) in capital expenditures (₩1.43 Billion). See GemVax&KAEL Co.Ltd net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.14x
Capex / Operating Cash Flow

Operating Cash Flow

₩10.34 Billion
KRW

Capital Expenditures

₩1.43 Billion
KRW

Data as of

Dec 2025
Most recent filing

GemVax&KAEL Co.Ltd Capital Reinvestment Ratio (2011–2025)

This chart tracks GemVax&KAEL Co.Ltd's Capital Reinvestment Ratio across 5 annual periods. Check 082270 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for GemVax&KAEL Co.Ltd (2011–2025)

Year-by-year Capital Reinvestment Ratio for GemVax&KAEL Co.Ltd from 2011 to 2025. For live market cap and broader valuation context, see how much is GemVax&KAEL Co.Ltd worth.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 1.91x ₩1.11 Billion ₩2.11 Billion ▼ -19.6%
2023 2.37x ₩3.57 Billion ₩8.46 Billion ▲ +219.2%
2020 0.74x ₩13.95 Billion ₩10.37 Billion ▲ +502.4%
2014 0.12x ₩10.64 Billion ₩1.31 Billion ▼ -70.9%
2011 0.42x ₩7.42 Billion ₩3.15 Billion
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow